Vyriad Secures $25M to Advance In Vivo CAR-T VV169
Rochester, Minnesota | December 23, 2025 — Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies, announced the...
Series B funding
Advertisement
Digitail Raises $23M Series B to Accelerate AI-Powered Vet Clinic Platform
Toronto, Canada – November 10, 2025 — Digitail, an AI-powered practice-management software platform for veterinary clinics, announced the completion...
AAVantgarde Secures $141 Million Series B to Advance Gene Therapies for Retinal Diseases
LONDON/MILAN, Nov. 3, 2025 — AAVantgarde Bio has raised $141 million in a Series B financing round, co-led by...
Advertisement
